MedTrace Logo

Lexapro in the Treatment of Patients With Postpartum Depression

NCT00277108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-11-06

No results posted yet for this study

Summary

The purpose of this study is to determine if Escitalopram (Lexapro) is effective in the treatment of postpartum depression.

Conditions

Interventions

DRUG

Escitalopram (Lexapro)

Sponsors & Collaborators

  • Forest Laboratories

    collaborator INDUSTRY

  • University of Rochester

    lead OTHER

Principal Investigators

  • Linda H Chaudron, MD, MS · University of Rochester

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2007-04-30
Completion
2007-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00277108 on ClinicalTrials.gov